Weight loss · Idaho
Wegovy & Zepbound in Idaho — on your insurance
Ondoc connects Idaho patients with licensed providers who bill your insurance for GLP-1 weight-loss medications. Prior-auth paperwork is handled. If insurance won't cover it, we route you to LillyDirect or manufacturer savings.
GLP-1 medications available to Idaho patients
Wegovy
semaglutide · GLP-1
Once-weekly GLP-1 injection FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Zepbound
tirzepatide · GIP/GLP-1
Dual GIP/GLP-1 receptor agonist. The strongest weight-loss results in head-to-head trials with semaglutide. Once-weekly injection.
Mounjaro
tirzepatide · GIP/GLP-1
Same molecule as Zepbound, FDA-approved for type 2 diabetes. Often prescribed off-label for weight loss when patients have insulin resistance or prediabetes.
Ozempic
semaglutide · GLP-1
Same molecule as Wegovy, dosed for type 2 diabetes. Frequently covered by insurance for T2D patients.
Saxenda
liraglutide · GLP-1
Daily GLP-1 injection. An option when weekly GLP-1s aren't covered or tolerated. FDA-approved for adolescents 12+ as well.
Foundayo
orforglipron · Other
Investigational once-daily oral GLP-1 receptor agonist — the first small-molecule oral GLP-1 in late-stage trials. No injection, no refrigeration. We'll prescribe at launch for eligible patients.
FAQs for Idaho patients
Will Ondoc bill my insurance for Wegovy or Zepbound?
Yes when your plan covers GLP-1s for weight management. We verify coverage and handle prior authorization paperwork. If your plan doesn't cover it, we'll tell you upfront and walk through self-pay alternatives like LillyDirect or manufacturer savings programs.
How is this different from Hims, Ro, or LillyDirect?
Those programs are cash-pay subscriptions or manufacturer direct-pay. Ondoc is insurance-first: a licensed provider reviews your case, bills your plan when possible, and only routes you to self-pay when insurance won't cover it. No monthly subscription lock-in.
Do I need a video visit?
Often no — for refills and established therapy, asynchronous review is enough. For new starts on a GLP-1, your prescriber may schedule a brief video visit to confirm BMI, comorbidities, and contraindications.
What if my insurance denies coverage?
Your prescriber files an appeal with clinical justification. If the denial holds, we'll route you to the manufacturer's self-pay program (LillyDirect for Zepbound, savings cards for Wegovy) so you don't lose continuity.
Are compounded GLP-1s an option?
We prescribe FDA-approved brand-name GLP-1s. Since the FDA shortage resolved, compounded semaglutide and tirzepatide are no longer broadly permitted under 503A/503B. We don't route to compounding pharmacies for these drugs.